194 related articles for article (PubMed ID: 29795381)
1. REGγ deficiency suppresses tumor progression via stabilizing CK1ε in renal cell carcinoma.
Chen S; Wang Q; Wang L; Chen H; Gao X; Gong D; Ma J; Kubra S; Yao X; Li X; Li L; Zhai W; Zheng J
Cell Death Dis; 2018 May; 9(6):627. PubMed ID: 29795381
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNA SNHG12 promotes tumour progression and sunitinib resistance by upregulating CDCA3 in renal cell carcinoma.
Liu Y; Cheng G; Huang Z; Bao L; Liu J; Wang C; Xiong Z; Zhou L; Xu T; Liu D; Yang H; Chen K; Zhang X
Cell Death Dis; 2020 Jul; 11(7):515. PubMed ID: 32641718
[TBL] [Abstract][Full Text] [Related]
3. REGγ Controls Hippo Signaling and Reciprocal NF-κB-YAP Regulation to Promote Colon Cancer.
Wang Q; Gao X; Yu T; Yuan L; Dai J; Wang W; Chen G; Jiao C; Zhou W; Huang Q; Cui L; Zhang P; Moses RE; Yang J; Chen F; Fu J; Xiao J; Li L; Dang Y; Li X
Clin Cancer Res; 2018 Apr; 24(8):2015-2025. PubMed ID: 29437787
[No Abstract] [Full Text] [Related]
4. EIF3D promotes sunitinib resistance of renal cell carcinoma by interacting with GRP78 and inhibiting its degradation.
Huang H; Gao Y; Liu A; Yang X; Huang F; Xu L; Danfeng X; Chen L
EBioMedicine; 2019 Nov; 49():189-201. PubMed ID: 31669222
[TBL] [Abstract][Full Text] [Related]
5. LINC00961 restrains cancer progression via modulating epithelial-mesenchymal transition in renal cell carcinoma.
Chen D; Zhu M; Su H; Chen J; Xu X; Cao C
J Cell Physiol; 2019 May; 234(5):7257-7265. PubMed ID: 30367453
[TBL] [Abstract][Full Text] [Related]
6. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
[TBL] [Abstract][Full Text] [Related]
7. Differential regulation of the REGγ-proteasome pathway by p53/TGF-β signalling and mutant p53 in cancer cells.
Ali A; Wang Z; Fu J; Ji L; Liu J; Li L; Wang H; Chen J; Caulin C; Myers JN; Zhang P; Xiao J; Zhang B; Li X
Nat Commun; 2013; 4():2667. PubMed ID: 24157709
[TBL] [Abstract][Full Text] [Related]
8. Proteasomes reactivator REG gamma enchances oncogenicity of MDA-MB-231 cell line via promoting cell proliferation and inhibiting apoptosis.
Tian M; Xiaoyi W; Xiaotao L; Guosheng R
Cell Mol Biol (Noisy-le-grand); 2009 Jun; 55 Suppl():OL1121-31. PubMed ID: 19656465
[TBL] [Abstract][Full Text] [Related]
9. Gankyrin is a novel biomarker for disease progression and prognosis of patients with renal cell carcinoma.
Wang C; Li Y; Chu CM; Zhang XM; Ma J; Huang H; Wang YN; Hong TY; Zhang J; Pan XW; Zheng JC; Jiang N; Hu CY; Ma X; Sun YH; Cui XG
EBioMedicine; 2019 Jan; 39():255-264. PubMed ID: 30558998
[TBL] [Abstract][Full Text] [Related]
10. SIRT1 downregulated FGB expression to inhibit RCC tumorigenesis by destabilizing STAT3.
Chen Y; Zhu Y; Sheng Y; Xiao J; Xiao Y; Cheng N; Chai Y; Wu X; Zhang S; Xiang T
Exp Cell Res; 2019 Sep; 382(2):111466. PubMed ID: 31201813
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of ALPK2 blocks development and progression of renal cell carcinoma.
Jiang J; Han P; Qian J; Zhang S; Wang S; Cao Q; Shao P
Exp Cell Res; 2020 Jul; 392(2):112029. PubMed ID: 32330508
[TBL] [Abstract][Full Text] [Related]
12. LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG.
Pu Y; Dong Z; Xia Y; Zhang M; Song J; Han J; Liu H
Biomed Pharmacother; 2019 Oct; 118():109382. PubMed ID: 31545257
[TBL] [Abstract][Full Text] [Related]
13. Knockdown of REGγ inhibits the proliferation and migration and promotes the apoptosis of multiple myeloma cells by downregulating NF-κB signal pathway.
Liu S; Zheng LL; Zhu YM; Shen HJ; Zhong Q; Huang J; Li C; Liu Z; Yao MD; Ou RM; Zhang Q
Hematology; 2018 Jun; 23(5):277-283. PubMed ID: 29020881
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA HOTTIP affects renal cell carcinoma progression by regulating autophagy via the PI3K/Akt/Atg13 signaling pathway.
Su Y; Lu J; Chen X; Liang C; Luo P; Qin C; Zhang J
J Cancer Res Clin Oncol; 2019 Mar; 145(3):573-588. PubMed ID: 30511250
[TBL] [Abstract][Full Text] [Related]
15. Mutant p53 (p53-R248Q) functions as an oncogene in promoting endometrial cancer by up-regulating REGγ.
Wang H; Bao W; Jiang F; Che Q; Chen Z; Wang F; Tong H; Dai C; He X; Liao Y; Liu B; Sun J; Wan X
Cancer Lett; 2015 May; 360(2):269-79. PubMed ID: 25697482
[TBL] [Abstract][Full Text] [Related]
16. REGγ accelerates melanoma formation by regulating Wnt/β-catenin signalling pathway.
Chen H; Gao X; Sun Z; Wang Q; Zuo D; Pan L; Li K; Chen J; Chen G; Hu K; Li K; Shah AS; Huang T; Muhammad Zeeshan B; Tong L; Jiao C; Liu J; Chen T; Yao L; Dang Y; Liu T; Li L
Exp Dermatol; 2017 Nov; 26(11):1118-1124. PubMed ID: 28605165
[TBL] [Abstract][Full Text] [Related]
17. Mir-451 Correlates with Prognosis of Renal Cell Carcinoma Patients and Inhibits Cellular Proliferation of Renal Cell Carcinoma.
Zhu S; Huang Y; Su X
Med Sci Monit; 2016 Jan; 22():183-90. PubMed ID: 26779781
[TBL] [Abstract][Full Text] [Related]
18. Proteasome activator REGγ promotes inflammation in Leydig cells via IkBε signaling.
Xie T; Chen H; Shen S; Huang T; Huang B; Hu G; Li L; Xu Y
Int J Mol Med; 2019 May; 43(5):1961-1968. PubMed ID: 30816488
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-33 Predicts Poor Prognosis and Promotes Renal Cell Carcinoma Cell Growth Through its Receptor ST2 and the JNK Signaling Pathway.
Wu CW; Wu YG; Cheng C; Hong ZD; Shi ZM; Lin SQ; Li J; He XY; Zhu AY
Cell Physiol Biochem; 2018; 47(1):191-200. PubMed ID: 29763892
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of ribosomal protein S15A inhibits human kidney cancer cell growth in vitro and in vivo.
Liang J; Liu Z; Zou Z; Wang X; Tang Y; Zhou C; Wu K; Zhang F; Lu Y
Mol Med Rep; 2019 Feb; 19(2):1117-1127. PubMed ID: 30569143
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
